
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $119.7B | $184.6B | $263.3B | $218.9B | $195.6B | |
Revenue Growth (YoY) | -32.08% | 54.24% | 42.61% | -16.85% | -10.66% | |
Cost of Revenues | $100.1B | $132.6B | $182.1B | $156.6B | $140.1B | |
Gross Profit | $19.6B | $52B | $81.2B | $62.4B | $55.5B | |
Gross Profit Margin | 16.38% | 28.17% | 30.84% | 28.49% | 28.39% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $1.7B | $3.1B | -$5.8B | $4B | $3B | |
Operating Expenses | $26.9B | $28.1B | $31.5B | $31.5B | $31.4B | |
Operating Income | -$7.3B | $23.9B | $49.7B | $30.9B | $24.1B | |
Net Interest Expenses | $1.4B | $1.1B | $609M | $84M | $290M | |
EBT. Incl. Unusual Items | -$7B | $26B | $43.3B | $34.8B | $26.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $318M | $9.6B | $22.2B | $13.3B | $10.8B | |
Net Income to Company | -$7.3B | $16.4B | $21B | $21.5B | $16B | |
Minority Interest in Earnings | $94M | -$334M | -$518M | -$126M | -$273M | |
Net Income to Common Excl Extra Items | -$7.2B | $16B | $20.5B | $21.4B | $15.8B | |
Basic EPS (Cont. Ops) | -$2.90 | $5.95 | $7.91 | $8.72 | $6.74 | |
Diluted EPS (Cont. Ops) | -$2.90 | $5.92 | $7.85 | $8.67 | $6.69 | |
Weighted Average Basic Share | $2.6B | $2.6B | $2.6B | $2.4B | $2.3B | |
Weighted Average Diluted Share | $2.6B | $2.6B | $2.6B | $2.4B | $2.3B | |
EBITDA | $17.9B | $42.1B | $59B | $50.8B | $42.3B | |
EBIT | -$5B | $27.7B | $45.4B | $37B | $29.2B | |
Revenue (Reported) | $119.7B | $184.6B | $263.3B | $218.9B | $195.6B | |
Operating Income (Reported) | -$7.3B | $23.9B | $49.7B | $30.9B | $24.1B | |
Operating Income (Adjusted) | -$5B | $27.7B | $45.4B | $37B | $29.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $38.6B | $64B | $58.2B | $51.9B | $47.9B | |
Revenue Growth (YoY) | 0.15% | 65.53% | -8.94% | -10.91% | -7.68% | |
Cost of Revenues | $26.7B | $43.3B | $41.4B | $36.7B | $33.9B | |
Gross Profit | $11.9B | $20.6B | $16.8B | $15.2B | $14B | |
Gross Profit Margin | 30.83% | 32.25% | 28.88% | 29.22% | 29.32% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $580M | -$2.1B | $1B | $1.5B | $619M | |
Operating Expenses | $7B | $8.5B | $7.9B | $7.7B | $7.6B | |
Operating Income | $4.9B | $12.1B | $8.9B | $7.4B | $6.4B | |
Net Interest Expenses | $392M | $180M | $242M | $145M | $366M | |
EBT. Incl. Unusual Items | $5.1B | $9.9B | $9.7B | $8.7B | $6.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6B | $4.8B | $4.1B | $2.9B | $2.7B | |
Net Income to Company | $3.4B | $5.1B | $5.6B | $5.8B | $3.9B | |
Minority Interest in Earnings | -$68M | -$107M | -$74M | -$83M | -$70M | |
Net Income to Common Excl Extra Items | $3.3B | $4.9B | $5.6B | $5.7B | $3.9B | |
Basic EPS (Cont. Ops) | $1.24 | $1.87 | $2.23 | $2.42 | $1.69 | |
Diluted EPS (Cont. Ops) | $1.23 | $1.85 | $2.21 | $2.40 | $1.68 | |
Weighted Average Basic Share | $2.7B | $2.6B | $2.5B | $2.4B | $2.3B | |
Weighted Average Diluted Share | $2.7B | $2.6B | $2.5B | $2.5B | $2.3B | |
EBITDA | $9B | $14.9B | $13.6B | $12.5B | $10.5B | |
EBIT | $5.5B | $10.3B | $10.4B | $9.5B | $7.4B | |
Revenue (Reported) | $38.6B | $64B | $58.2B | $51.9B | $47.9B | |
Operating Income (Reported) | $4.9B | $12.1B | $8.9B | $7.4B | $6.4B | |
Operating Income (Adjusted) | $5.5B | $10.3B | $10.4B | $9.5B | $7.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $119.8B | $210B | $257.6B | $212.6B | $191.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $94.8B | $148.8B | $179.8B | $151.1B | $137.2B | |
Gross Profit | $25B | $61.2B | $77.8B | $61.5B | $54.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $871M | -$251M | -$3.3B | $3.6B | $2.1B | |
Operating Expenses | $26.2B | $29.1B | $30.5B | $30.8B | $31.3B | |
Operating Income | -$1.2B | $32.1B | $47.4B | $30.6B | $23.1B | |
Net Interest Expenses | $1.6B | $1.1B | $942M | $368M | $511M | |
EBT. Incl. Unusual Items | -$1.9B | $30.8B | $43.1B | $33.9B | $24.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2B | $12.8B | $21.5B | $12.2B | $10.6B | |
Net Income to Company | -$3.9B | $18B | $21.6B | $21.7B | $14.1B | |
Minority Interest in Earnings | -$6M | -$373M | -$485M | -$135M | -$260M | |
Net Income to Common Excl Extra Items | -$3.9B | $17.6B | $21.1B | $21.5B | $13.9B | |
Basic EPS (Cont. Ops) | -$1.68 | $6.58 | $8.26 | $8.92 | $5.99 | |
Diluted EPS (Cont. Ops) | -$1.69 | $6.53 | $8.19 | $8.86 | $5.94 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $22.7B | $48.1B | $58.1B | $50.3B | $40.3B | |
EBIT | $112M | $32.7B | $45.8B | $36.7B | $27.1B | |
Revenue (Reported) | $119.8B | $210B | $257.6B | $212.6B | $191.6B | |
Operating Income (Reported) | -$1.2B | $32.1B | $47.4B | $30.6B | $23.1B | |
Operating Income (Adjusted) | $112M | $32.7B | $45.8B | $36.7B | $27.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $38.6B | $64B | $58.2B | $51.9B | $47.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $26.7B | $43.3B | $41.4B | $36.7B | $33.9B | |
Gross Profit | $11.9B | $20.6B | $16.8B | $15.2B | $14B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $580M | -$2.1B | $1B | $1.5B | $619M | |
Operating Expenses | $7B | $8.5B | $7.9B | $7.7B | $7.6B | |
Operating Income | $4.9B | $12.1B | $8.9B | $7.4B | $6.4B | |
Net Interest Expenses | $392M | $180M | $242M | $145M | $366M | |
EBT. Incl. Unusual Items | $5.1B | $9.9B | $9.7B | $8.7B | $6.7B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6B | $4.8B | $4.1B | $2.9B | $2.7B | |
Net Income to Company | $3.4B | $5.1B | $5.6B | $5.8B | $3.9B | |
Minority Interest in Earnings | -$68M | -$107M | -$74M | -$83M | -$70M | |
Net Income to Common Excl Extra Items | $3.3B | $4.9B | $5.6B | $5.7B | $3.9B | |
Basic EPS (Cont. Ops) | $1.24 | $1.87 | $2.23 | $2.42 | $1.69 | |
Diluted EPS (Cont. Ops) | $1.23 | $1.85 | $2.21 | $2.40 | $1.68 | |
Weighted Average Basic Share | $2.7B | $2.6B | $2.5B | $2.4B | $2.3B | |
Weighted Average Diluted Share | $2.7B | $2.6B | $2.5B | $2.5B | $2.3B | |
EBITDA | $9B | $14.9B | $13.6B | $12.5B | $10.5B | |
EBIT | $5.5B | $10.3B | $10.4B | $9.5B | $7.4B | |
Revenue (Reported) | $38.6B | $64B | $58.2B | $51.9B | $47.9B | |
Operating Income (Reported) | $4.9B | $12.1B | $8.9B | $7.4B | $6.4B | |
Operating Income (Adjusted) | $5.5B | $10.3B | $10.4B | $9.5B | $7.4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $31.3B | $21.3B | $33B | $27.3B | $24B | |
Short Term Investments | $4.5B | $12.1B | $8.6B | $6.2B | $6.5B | |
Accounts Receivable, Net | $14.1B | $22B | $24.4B | $23.4B | $19.3B | |
Inventory | $14.7B | $20B | $22.9B | $19.3B | $18.9B | |
Prepaid Expenses | $1.8B | $1.9B | $1.5B | $1.7B | $2.5B | |
Other Current Assets | $53M | $53M | $63M | $60M | $71M | |
Total Current Assets | $79.7B | $111.1B | $125.7B | $99.5B | $96.6B | |
Property Plant And Equipment | $130.8B | $128B | $128.1B | $129.3B | $128.9B | |
Long-Term Investments | $26.7B | $30.1B | $27.4B | $30.9B | $33B | |
Goodwill | $8.8B | $8.8B | $8.7B | $10B | $11.3B | |
Other Intangibles | $2.2B | $2.2B | $2.3B | $2.8B | $3.1B | |
Other Long-Term Assets | $65M | $378M | $301M | $330M | $154M | |
Total Assets | $266.1B | $293.5B | $303.9B | $283.7B | $285.5B | |
Accounts Payable | $23.6B | $36.8B | $41.3B | $41.3B | $39.9B | |
Accrued Expenses | $2.4B | $5.2B | $2.3B | $2.8B | $3.2B | |
Current Portion Of Long-Term Debt | $15.9B | $13.6B | $14.1B | $7.9B | $7.9B | |
Current Portion Of Capital Lease Obligations | $1.2B | $1.4B | $1.4B | $1.7B | $2.1B | |
Other Current Liabilities | $15.8B | $27.7B | $35.8B | $21.1B | $22.3B | |
Total Current Liabilities | $64.7B | $95.1B | $109.8B | $88.8B | $88B | |
Long-Term Debt | $58.6B | $48B | $41.5B | $38.3B | $41.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $160B | $178.5B | $189.3B | $164.2B | $165.2B | |
Common Stock | $8.3B | $8.2B | $8.2B | $7.6B | $7.6B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $103.7B | $111.7B | $111.7B | $116.8B | $117.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.4B | $3.3B | $2.8B | $2.7B | $2.4B | |
Total Equity | $106.1B | $115B | $114.6B | $119.5B | $120.3B | |
Total Liabilities and Equity | $266.1B | $293.5B | $303.9B | $283.7B | $285.5B | |
Cash and Short Terms | $35.8B | $33.5B | $41.6B | $33.4B | $30.5B | |
Total Debt | $74.5B | $61.7B | $55.6B | $46.1B | $49.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $30.3B | $31.3B | $28B | $25.6B | $22.8B | |
Short Term Investments | $4.6B | $7.4B | $7.5B | $6.3B | $6.2B | |
Accounts Receivable, Net | $17.5B | $32B | $24.1B | $24.2B | $24.9B | |
Inventory | $16.2B | $24.5B | $22.8B | $20.2B | $19B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $14.3B | $51B | $28.2B | $20.6B | $22.4B | |
Total Current Assets | $83.3B | $147B | $111.3B | $97.5B | $97.1B | |
Property Plant And Equipment | $106.9B | $104.5B | $107.5B | $109.5B | $112.2B | |
Long-Term Investments | $36.5B | $32.3B | $33.6B | $35.5B | $39.8B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.6B | $3B | $2.7B | $4.3B | $4B | |
Total Assets | $269.2B | $324.6B | $293B | $283.1B | $291.1B | |
Accounts Payable | $27B | $46.9B | $36B | $37.6B | $42.6B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $20.5B | $18.3B | $17.9B | $18B | $13.1B | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $512M | $545M | $764M | $588M | $2.3B | |
Total Current Liabilities | $70B | $122.6B | $97.3B | $89.2B | $90.5B | |
Long-Term Debt | $52.5B | $46.5B | $42.9B | $38.1B | $45.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $157.5B | $204.7B | $174.6B | $162B | $170.6B | |
Common Stock | $8.2B | $8.1B | $7.8B | $7.5B | $7.2B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.4B | $3.4B | $2.9B | $2.7B | $2.5B | |
Total Equity | $111.7B | $119.9B | $118.4B | $121.1B | $120.4B | |
Total Liabilities and Equity | $269.2B | $324.6B | $293B | $283.1B | $291.1B | |
Cash and Short Terms | $34.9B | $38.7B | $35.5B | $32B | $29.1B | |
Total Debt | $73B | $64.8B | $60.8B | $56B | $59B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.3B | $16.4B | $21B | $21.5B | $16B | |
Depreciation & Amoritzation | $22.9B | $14.3B | $13.7B | $13.8B | $13.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $4.8B | -$6.8B | -$3.3B | $306M | $3.9B | |
Change in Inventories | $2.3B | -$5.9B | -$3.8B | $3.2B | -$203M | |
Cash From Operations | $14.8B | $30.4B | $47.4B | $40.7B | $30.9B | |
Capital Expenditures | $10.8B | $12.3B | $15.7B | $17.7B | $14.9B | |
Cash Acquisitions | -$2.8B | -$2.7B | -$2.3B | -$1.7B | -$2.4B | |
Cash From Investing | -$13.1B | -$13.7B | -$15.1B | -$16.5B | -$17.3B | |
Dividends Paid (Ex Special Dividend) | -$6.7B | -$8.2B | -$10B | -$7.5B | -$7.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $16.1B | $3.2B | $1.1B | $189M | $7.6B | |
Long-Term Debt Repaid | -$315M | -$672M | -$379M | -$1.5B | -$802M | |
Repurchase of Common Stock | -$611M | -$1.8B | -$7.7B | -$9.2B | -$8B | |
Other Financing Activities | -$992M | -$7.5B | $3.4B | $2.1B | -$853M | |
Cash From Financing | $1.4B | -$25.5B | -$19.3B | -$29.7B | -$14.4B | |
Beginning Cash (CF) | $27.4B | $31.3B | $21.3B | $33B | $27.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $3.1B | -$8.7B | $13B | -$5.5B | -$903M | |
Ending Cash (CF) | $31.3B | $21.3B | $33B | $27.3B | $25.8B | |
Levered Free Cash Flow | $4B | $18.1B | $31.7B | $23B | $15.9B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.3B | $5.8B | $4.2B | $3.8B | -- | |
Depreciation & Amoritzation | $3.3B | $3.3B | $3.2B | $3.1B | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $7.6B | $16.3B | $9.9B | $9B | -- | |
Capital Expenditures | $2.7B | $5.2B | $3.9B | $3.7B | -- | |
Cash Acquisitions | -$477M | -$155M | -$503M | -$519M | -- | |
Cash From Investing | -$3.1B | -$5B | -$4.5B | -$4.6B | -- | |
Dividends Paid (Ex Special Dividend) | -$2.1B | -$1.8B | -$1.8B | -$1.9B | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -$1.5B | -$14M | $4.3B | -- | |
Long-Term Debt Repaid | -$96M | -$138M | -$1.2B | -$1.7B | -- | |
Repurchase of Common Stock | -$165M | -$2B | -$2B | -$2B | -- | |
Other Financing Activities | -$120M | -$838M | $872M | -$676M | -- | |
Cash From Financing | -$6.3B | -$8.6B | -$7.9B | -$6.8B | -- | |
Beginning Cash (CF) | $30.3B | $31.3B | $28B | $25.6B | -- | |
Foreign Exchange Rate Adjustment | $209M | -$1.2B | $35M | -$57M | -- | |
Additions / Reductions | -$1.9B | $2.7B | -$2.4B | -$2.4B | -- | |
Ending Cash (CF) | $28.6B | $32.8B | $25.6B | $23.2B | -- | |
Levered Free Cash Flow | $4.9B | $11.1B | $6B | $5.3B | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.9B | $18B | $21.6B | $21.7B | $14.1B | |
Depreciation & Amoritzation | $22.6B | $15.4B | $12.3B | $13.7B | $13.2B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $19.1B | $32.4B | $44.9B | $37.7B | $31.2B | |
Capital Expenditures | $10.8B | $13.4B | $17.2B | $16.2B | $15.7B | |
Cash Acquisitions | -$3.1B | -$834M | -$3.7B | -$357M | -$2.8B | |
Cash From Investing | -$13.5B | -$11.9B | -$19.1B | -$13.6B | -$18.7B | |
Dividends Paid (Ex Special Dividend) | -$6.9B | -$8.1B | -$9.9B | -$7.6B | -$7.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $19.3B | $2B | -$726M | $113M | $11B | |
Long-Term Debt Repaid | -$1.2B | $169M | -$401M | -$1.5B | -$1.9B | |
Repurchase of Common Stock | -- | -$3B | -$8.6B | -$9.1B | -$8.1B | |
Other Financing Activities | $1.8B | -$1.8B | -$931M | $1.1B | -$542M | |
Cash From Financing | $2.3B | -$18.7B | -$28.2B | -$26B | -$15.3B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8B | $1.9B | -$2.4B | -$1.8B | -$2.7B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $8.3B | $19B | $27.7B | $21.5B | $15.5B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.7B | $10.9B | $9.8B | $9.7B | $3.9B | |
Depreciation & Amoritzation | $6.8B | $7.9B | $6.4B | $6.1B | $3.1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $13.1B | $23.9B | $15B | $11.2B | $2.6B | |
Capital Expenditures | $5.1B | $8.6B | $8.8B | $7.1B | $4.2B | |
Cash Acquisitions | -$2.4B | -$156M | -$1.9B | -$548M | -$426M | |
Cash From Investing | -$7.3B | -$7.4B | -$10.8B | -$8B | -$4.8B | |
Dividends Paid (Ex Special Dividend) | -$4.2B | -$3.8B | -$3.7B | -$3.8B | -$1.9B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $3.2B | $542M | $104M | $4.4B | $3.4B | |
Long-Term Debt Repaid | -$1.1B | -$274M | -$1.3B | -$1.8B | -$1.3B | |
Repurchase of Common Stock | -$165M | -$3.2B | -$4.1B | -$4B | -$2.2B | |
Other Financing Activities | -$333M | $4.7B | $2.2B | -$428M | $559M | |
Cash From Financing | -$8.2B | -$3.6B | -$11.8B | -$7.1B | -$1.1B | |
Beginning Cash (CF) | $61.6B | $52.6B | $61B | $52.9B | $25.8B | |
Foreign Exchange Rate Adjustment | -$329M | -$1.5B | $197M | -$140M | $365M | |
Additions / Reductions | -$2.3B | $13B | -$7.7B | -$3.9B | -$3.4B | |
Ending Cash (CF) | $58.9B | $64.1B | $53.6B | $48.9B | $22.8B | |
Levered Free Cash Flow | $8.1B | $15.3B | $6.2B | $4.1B | -$1.7B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.